Skip to main content

Table 1 Quality of life weights* corresponding to different cancer stages

From: Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary

 

Non-detected

Newly detected

Treated

CC I-IIA

1.0 (0.1000)

0.68 (0.0680)

0.95 (0.0950)

CC IIB-III

0.95 (0.0950)

0.56 (0.0560)

0.75 (0.0750)

CC IV

0.9 (0.0900)

0.48 (0.0480)

0.60 (0.0600)

  1. The numbers in brackets are the standard errors applied for the distributions in the probabilistic sensitivity analysis.
  2. *The age specific quality of life weights are multiplied with these weights.
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us